RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
RBC Capital has maintained its Sector Perform rating for Bausch Health Companies (NYSE:BHC) and increased its price target from $8.00 to $9.00. BHC's shares are currently trading up 0.54% at $9.35, which is above the new target. Bausch Health is a global company focusing on branded products for dermatology, gastrointestinal, and ophthalmology markets, with Bausch + Lomb being its highest revenue segment.
February 23, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital maintains Sector Perform rating for BHC and raises price target to $9. Shares are trading above this target at $9.35.
The maintenance of the Sector Perform rating and the increase in price target by RBC Capital suggest a neutral to slightly positive outlook for BHC. However, since the shares are already trading above the new target, the immediate impact on the stock price might be limited. The analyst's rating and target adjustments are based on their assessment of the company's performance and market position, particularly in its key segments.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100